Evaluation of a new tuberculosis-related interferon gamma release assay for tuberculosis infection diagnosis in Huzhou, eastern China

Indian Journal of Pathology and Microbiology

Volumn 56, Issue 2, 2013, Pages 125-128

  Qian, Fuchu ^a   Wang, Weihong ^a   Qiu, Zhihong ^b   Shen, Yiqun ^a   He, Jiangfang ^a   Li, Dongli ^a   Zhong, Jing ^a   Dai, Licheng ^a  

^a HUZHOU CENTRAL HOSPITAL   (China)

^b Huzhou Center for Disease Prevention and Control   (China)

Author keywords

QuantiFERON TB gold in tube; TB related interferon gamma release assay; Tuberculosis infection

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; BIOASSAY; BLOOD SAMPLING; CHINA; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTESTINE TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; TUBERCULOSIS RELATED INTERFERON GAMMA RELEASE ASSAY; TUBERCULOUS MENINGITIS; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; AGED; CHINA; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

EID: 84885406425     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.118694     Document Type: Article

References (21)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report. Geneva, Switzerland: World Health Organization; 2008.
2. National technic steering group of the epidemiological sampling survey of tuberculosis. Report on fourth national epidemiological sampling survey of tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 2002;25:3-6.
3. Rose DN, Schechter CB, Adler JJ. Interpretation of the tuberculosis skin test. J Gen Intern Med 1995;10:635-42.
4. Arnadottir T, Rieder HL, Trebucq A, Waaler HT. Guidenlines for conducting tuberculosis skin test surveys in high prevalence countries. Tuber Lung Dis 1996;77:1-19.
5. Johnson PD, Stuart RL, Grayson ML, Olden D, Clancy A, Ravn P, et al. Tuberculin-purified protein derivative-, MPT64-, and ESAT-6 stimulated gamma interferon response in medical student before and after mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999;6:934-7.
6. van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000;7:155-60.
7. Lalvani A. Diagnosis Tuberculosis infection in the 21st century: New tools to tackle an old enemy. Chest 2007;131:1898-906.
8. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95.
9. Cellestis. QuantiFERON®-TB Gold (In-Tube Method) [package insert]. Carnegie, VIC, Australia: Cellestis; 2006.
10. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J 2011;37:100-11.
11. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010;25:1-25.
12. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64.
13. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-61.
14. Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD, Nielsen LN, et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005;12:491-6.
15. Nishimura T, Hasegawa N, Mori M, Takebayashi T, Harada N, Higuchi K, et al. Accuracy of an interferon-gamma release assay to detect active pulmonary and extra-pulmonary tuberculosis. Int J Tuberc Lung Dis 2008;12:269-74.
16. Kim SH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis. Arch Intern Med 2007;167:2255-9.
17. Lee HM, Shin JW, Kim JY, Park IW, Choi BW, Choi JC, et al. HRCT and whole-blood interferon-gamma assay for the rapid diagnosis of smear-negative pulmonary tuberculosis. Respiration 2010;79:454-60.
18. Lai CC, Tan CK, Lin SH, Liao CH, Huang YT, Hsueh PR. Diagnostic performance of whole-blood interferon-γ assay and enzyme-linked immunospot assay for active tuberculosis. Diagn Microbiol Infect Dis 2011;71:139-43.
19. Moyo S, Isaacs F, Gelderbloem S, Verver S, Hawkridge AJ, Hatherill M, et al. Tuberculin skin test and QuantiFERON®assay in young children investigated for tuberculosis in South Africa. Int J Tuberc Lung Dis 2011;15:1176-81.
20. Ra SW, Lyu J, Choi CM, Oh YM, Lee SD, Kim WS, et al. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay. Int J Tuberc Lung Dis 2011;15:635-40.
21. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis. Chest 2010;137:952-68.